Study of Mitomycin C and Nasal Splint to Treat Nasal Synechiae
Comparative Study of Mitomycin C and Internal Nasal Septal Splint in the Treatment of Nasal Synechiae
1 other identifier
interventional
60
1 country
1
Brief Summary
This study evaluates whether Mitomycin C is an effective alternative to septal splints in the treatment of nasal synechiae.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Oct 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 25, 2009
CompletedFirst Posted
Study publicly available on registry
August 26, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2009
CompletedJuly 8, 2011
August 1, 2009
1.3 years
August 25, 2009
July 7, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence or absence of synechiae
1 week, 1 month, 2 months
Secondary Outcomes (1)
Symptoms and complications
1 week, 1 month, 2 months
Study Arms (2)
Mitomycin C
ACTIVE COMPARATORCases recruited into this arm receive topical application of mitomycin c (1mg/ml)following surgical synechiolysis
Teflon septal splint
ACTIVE COMPARATORCases recruited into this arm receive insertion of teflon internal nasal septal splint following surgical synechiolysis
Interventions
Cotton wick soaked with 1mg/ml of mitomycin c placed for 2 minutes between the raw surfaces after synechiolysis with surgical blade no.15
Teflon internal nasal septal splint placed between the raw surfaces and secured at the anterior end of septum with catgut 3-0 sutures, following synechiolysis with surgical blade no.15. Splint removed at the end of one week
Eligibility Criteria
You may qualify if:
- Patients with nasal mucosal synechiae due to surgical or non-surgical trauma
You may not qualify if:
- Patients with nasal vestibular stenosis
- Patients with nasal synechiae due to diseases like Hansen's disease, Syphilis, Rhinoscleroma, Atrophic Rhinitis etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karnataka Institute of Medical Sciences
Hubli, Karnataka, 580022, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
VIKRAM K BHAT, MS(ENT), DNB
Karnataka Institute of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 25, 2009
First Posted
August 26, 2009
Study Start
October 1, 2007
Primary Completion
February 1, 2009
Study Completion
September 1, 2009
Last Updated
July 8, 2011
Record last verified: 2009-08